ExodusPoint Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-152,327	Closed	-$3M	–	1636
2025 Q3	$3M	Buy	152,327 +106,878	+235%	+$2.2M	0.04%	590
2025 Q2	$986K	Buy	+45,449	New	+$1.07M	0.01%	965
2024 Q1	–	Sell	-39,077	Closed	-$657K	–	1563
2023 Q4	$657K	Buy	+39,077	New	+$534K	0.01%	961
2023 Q2	–	Sell	-121,122	Closed	-$2.01M	–	1912
2023 Q1	$2.01M	Buy	+121,122	New	+$2M	0.02%	873
2022 Q3	–	Sell	-203,993	Closed	-$1.43M	–	1935
2022 Q2	$1.43M	Buy	203,993 +182,242	+838%	+$1.34M	0.02%	927
2022 Q1	$180K	Sell	21,751 -39,564	-65%	-$280K	﹤0.01%	1935
2021 Q4	$415K	Sell	61,315 -10,194	-14%	-$67K	0.01%	1511
2021 Q3	$379K	Buy	71,509 +45,191	+172%	+$247K	0.01%	1526
2021 Q2	$151K	Buy	+26,318	New	+$136K	﹤0.01%	2058
2021 Q1	–	Sell	-41,827	Closed	-$140K	–	2175
2020 Q4	$140K	Buy	+41,827	New	+$141K	﹤0.01%	1797
2020 Q3	–	Sell	-10,235	Closed	-$47K	–	1813
2020 Q2	$47K	Buy	+10,235	New	+$46K	﹤0.01%	1686